Serial Biopsies Reveal Immune Activation During Treatment for Recurrent Glioblastoma
A recent multi-institutional study has demonstrated that repeated sampling of brain tumor tissue can reveal immune system activation in response to cancer treatment for patients with recurrent glioblastoma (GBM). The research, conducted by the Accelerating GBM Therapies Through Serial Biopsies TeamLab and led by investigators from the Mass General Brigham Cancer Institute, highlights the potential of serial biopsies to detect treatment responses that may not be visible through traditional imaging techniques.
UPDATES AND NEWS
Real-Time Biopsies Reveal Hidden Insights into Glioblastoma Therapy Response | Bioengineer.org
Experimental Glioblastoma Trial Findings Could Lead to Change in Patient Monitoring and Therapy | GEN
Real-Time Biopsies Uncover Hidden Response to Glioblastoma Therapy
Break Through Cancer launches a $15M multi-institute pediatric osteosarcoma research initiative | The Cancer Letter
BE PART OF THE MISSION
Stay Informed, Make an Impact
Subscribe
Be the first to hear about cutting-edge research, pioneering projects, and the latest advancements in Break Through Cancer science. Sign up to stay informed.
Give
Your contribution fuels groundbreaking research in some of the most challenging cancers. Every gift accelerates progress. For more information please contact Michaela Forand at MF@breakthroughcancer.org or 1-800-757-9881 ext 2.